Related Experiment Video
Updated: Sep 29, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Do children with falling blood lead levels have improved cognition?
Xianchen Liu1, Kim N Dietrich, Jerilynn Radcliffe
1Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
Insights
Cognitive improvements in children with elevated blood lead levels were observed in a study, but these gains were not directly linked to lead reduction via chelation therapy. Other factors appear to influence cognitive development.
Area of Science:
- Environmental Health
- Pediatric Neurology
- Toxicology
Background:
- Lead exposure in urban children is linked to impaired cognitive development.
- Previous studies yielded conflicting results on the efficacy of chelation therapy for improving IQ in children with lead exposure.
Purpose of the Study:
- To re-analyze data from a randomized clinical trial on chelation therapy for lead exposure.
- To investigate the association between changes in blood lead levels and cognitive development in young children.
Main Methods:
- A secondary analysis of a randomized trial involving 741 children (13-33 months old) with blood lead levels of 20-44 microg/dL.
- Blood lead levels and cognitive test scores were measured at baseline, 6 months, and 36 months.
- Change in blood lead level was used as the independent variable to assess its impact on cognitive test scores.
Main Results:
- Blood lead levels decreased similarly in both chelation and placebo groups by 6 months.
- No association was found between blood lead level reduction and cognitive score changes at 6 months.
- In the placebo group, cognitive scores increased by 4.0-5.1 points per 10 microg/dL fall in blood lead level from baseline to 36 months.
Conclusions:
- Cognitive improvements in children with lead exposure may be influenced by factors other than the direct effect of lead level reduction.
- The active drug, succimer, is unlikely to be responsible for cognitive impairment, though it cannot be entirely ruled out.
Objective:
Exposure to lead at levels encountered by urban children impairs cognitive development. An observational study suggested improvement in IQ when blood lead level fell, but the only randomized trial of chelation showed no benefit in IQ.
Methods:
We did a new analysis of the data from the clinical trial using change in blood lead level as the independent variable. The 741 children began with blood lead levels between 20 and 44 microg/dL, and were 13 to 33 months old at randomization to chelation or placebo. Blood lead levels were measured repeatedly, and cognitive tests were given at baseline, 6 months, and 36 months follow-up.
Results:
By 6 months after randomization, blood lead levels had fallen by similar amounts in both chelated and placebo children, despite the immediate drops in the chelated group; there was no association between change in blood lead level and change in cognitive test score. Blood lead levels continued to fall. At 36 months follow-up, in the placebo group only, cognitive test scores had increased 4.0 points per 10 microg/dL fall in blood lead level from baseline to 36 months follow-up and 5.1 points from 6 to 36 months.
Conclusions:
The improvement in scores in the placebo group only implies that factors other than declining blood lead levels per se are responsible for cognitive improvement; it is possible but less likely that succimer, the active drug, impairs cognition.
More Related Videos
Related Concept Videos
Information Processing Approach
Environmental Influences on Intelligence
Language and Cognition
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Cognitive Development During Adulthood
Role of Neurotransmitters in Memory
Ā Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...

